• ABOUT US
    ▼
    • Our Vision
    • Leadership Team
  • OUR RESEARCH
    ▼
    • Our Approach
    • Publications
    • Conferences
  • PROGRAMS
    ▼
    • Pipeline
    • VIS649 Sibeprenlimab
    • VIS171
    • VIS513
  • FOR PATIENTS
    ▼
    • Clinical Trials
    • IgA Nephropathy
  • CAREERS
    ▼
    • Open Positions & Benefits
    • Our Culture
    • Co-op program
  • Contact

Visterra

We Bring Better Biologics to Life

  • ABOUT US
    • Our Vision
    • Leadership Team
  • OUR RESEARCH
    • Our Approach
    • Publications
    • Conferences
  • PROGRAMS
    • Pipeline
    • VIS649 Sibeprenlimab
    • VIS171
    • VIS513
  • FOR PATIENTS
    • Clinical Trials
    • IgA Nephropathy
  • CAREERS
    • Open Positions & Benefits
    • Our Culture
    • Co-op program
  • Contact

A Global Randomized, Double-Blind, Placebo-Controlled Study Evaluating Safety And Efficacy Of Vis410 In Combination With Oseltamivir Versus Oseltamivir Alone In Hospitalized Adults With Influenza A Requiring Oxygen

August 28, 2019 | International Society for Influenza and Respiratory Viruses (ISIRV) 'OPTIONS X' Conference
Schaefers, et. al.

A Global Randomized, Double-Blind, Placebo-Controlled Study Evaluating Safety And Efficacy Of Vis410 In Combination With Oseltamivir Versus Oseltamivir Alone In Hospitalized Adults With Influenza A Requiring Oxygen

Kristi Schaefers, Kristin Narayan, Susan Sloan, David Oldach, other authors

© 2023 Visterra, Inc. Terms of usePrivacy PolicySite Design: Fassino/Design